1.
2.
3.
4.
5.
6.
Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP,
et al. Get with the guidelines scientific advisory committee and
investigators. Trends in patients hospitalized with heart failure and
preserved left ventricular ejection fraction: prevalence, therapies, and
outcomes. Circulation. 2012;126:65–75.
Redfield MM. Heart failure with preserved ejection fraction. N Engl J Med.
2016;375:1868–77.
Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure--abnormalities in active
relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350:
1953–9.
Westermann D, Kasner M, Steendijk P, Spillmann F, Riad A, Weitmann K,
et al. Role of left ventricular stiffness in heart failure with normal ejection
fraction. Circulation. 2008;117:2051–60.
Rommel KP, von Roeder M, Latuscynski K, Oberueck C, Blazek S, Fengler K,
et al. Extracellular volume fraction for characterization of patients with heart
failure and preserved ejection fraction. J Am Coll Cardiol. 2016;67:1815–25.
Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, et al.
Impaired systolic function by strain imaging in heart failure with preserved
ejection fraction. J Am Coll Cardiol. 2014;63:447–56.
Ito et al. Journal of Cardiovascular Magnetic Resonance
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
(2020) 22:42
Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, Liu L, et al. Prognostic
importance of impaired systolic function in heart failure with preserved
ejection fraction and the impact of spironolactone. Circulation. 2015;132:
402–14.
Pedrizzetti G, Claus P, Kilner PJ, Nagel E. Principles of cardiovascular
magnetic resonance feature tracking and echocardiographic speckle
tracking for informed clinical use. J Cardiovasc Magn Reson. 2016;18:51.
Okuda S, Yano M. Guidelines for treatment of chronic heart failure (JCS
2010). Nihon Rinsho. 2011;69:595–604.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al.
2016 ESC guidelines for the diagnosis and treatment of acute and chronic
heart failure. Rev Esp Cardiol (Engl Ed). 2016;69:1167.
Moriwaki K, Takeuchi T, Fujimoto N, Sawai T, Sato Y, Kumagai N, et al. Effect of
Sitagliptin on coronary flow reserve assessed by magnetic resonance imaging in
type 2 diabetic patients with coronary artery disease. Circ J. 2018;82:2119–27.
Nakamori S, Dohi K, Ishida M, Goto Y, Imanaka-Yoshida K, Omori T, et al.
Native T1 mapping and extracellular volume mapping for the assessment of
diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc
Imaging. 2018;11:48–59.
Kawaji K, Codella NC, Prince MR, Chu CW, Shakoor A, LaBounty TM, et al.
Automated segmentation of routine clinical cardiac magnetic resonance
imaging for assessment of left ventricular diastolic dysfunction. Circ
Cardiovasc Imaging. 2009;2:476–84.
Su MY, Lin LY, Tseng YH, Chang CC, Wu CK, Lin JL, et al. CMR-verified
diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
JACC Cardiovasc Imaging. 2014;7:991–7.
Wei J, Mehta PK, Shufelt C, Yang Y, Gill E, Kahlon R, et al. Diastolic
dysfunction measured by cardiac magnetic resonance imaging in women
with signs and symptoms of ischemia but no obstructive coronary artery
disease. Int J Cardiol. 2016;220:775–80.
Zemrak F, Ambale-Venkatesh B, Captur G, Chrispin J, Chamera E, Habibi M,
et al. Left atrial structure in relationship to age, sex, ethnicity, and
cardiovascular risk factors: MESA (multi-ethnic study of atherosclerosis). Circ
Cardiovasc Imaging. 2017;10.
Tsao CW, Josephson ME, Hauser TH, Halloran TDO’, Agarwal A, Manning WJ,
et al. Accuracy of electrocardiographic criteria for atrial enlargement:
validation with cardiovascular magnetic resonance. J Cardiovasc Magn
Reson. 2008;10:7.
Goto Y, Ishida M, Takase S, Sigfridsson A, Uno M, Nagata M, et al.
Comparison of displacement encoding with stimulated echoes to magnetic
resonance feature tracking for the assessment of myocardial strain in
patients with acute myocardial infarction. Am J Cardiol. 2017;119:1542–7.
Park J-H, Negishi K, Kwon DH, Popovic ZB, Grimm RA, Marwick TH.
Validation of global longitudinal strain and strain rate as reliable markers of
right ventricular dysfunction: comparison with cardiac magnetic resonance
and outcome. J Cardiovasc Ultrasound. 2014;22:113–20.
von Roeder M, Rommel KP, Kowallick JT, Blazek S, Besler C, Fengler K, et al.
Influence of left atrial function on exercise capacity and left ventricular
function in patients with heart failure and preserved ejection fraction. Circ
Cardiovasc Imaging. 2017;10.
Yamanaka T, Onishi K, Tanabe M, Dohi K, Yamanaka K, Fujimoto N, et al.
Force- and relazation-frequency relations in patients with diastolic heart
failure. Am Heart J. 2006;152:966.e1–7.
Little WC, Cheng CP, Peterson T, Vinten-Johansen J. Response of the left
ventricular end-systolic pressure-volume relation in conscious dogs to a
wide range of contractile states. Circulation. 1988;78:736–45.
Mizuno O, Onishi K, Dohi K, Motoyasu M, Okinaka T, Ito M, et al. Effect of
therapeutic doses of human atrial natriuretic peptide on load and
myocardial performance in patients with congestive heart failure. Am J
Cradiol. 2001;88:863–6.
Raff GL, Glantz SA. Volume loading slows left ventricular isovolumic
relaxation rate. Evidence of load-dependent relaxation in the intact dog
heart. Circ Res. 1981;48:813–24.
Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial
stiffening in patients with heart failure and preserved ejection fraction: implications
for systolic and diastolic reserve limitations. Circulation. 2003;107:714–20.
Hayashi T, Yamada S, Iwano H, Nakabachi M, Sakakibara M, Okada K, et al.
Left ventricular global strain for estimating relaxation and filling pressure- a
multicenter study. Circ J. 2016;80:1163–70.
Page 11 of 11
27. Eichhorn EJ, Willard JE, Alvarez L, Kim AS, Glamann DB, Risser RC, et al. Are
contraction and relaxation coupled in patients with and without congestive
heart failure? Circulation. 1992;85:2132–9.
28. Claus P, Omar AMS, Pedrizzetti G, Sengupta PP, Nagel E. Tissue tracking
Technology for Assessing Cardiac Mechanics: principles, Normal values, and
clinical applications. JACC Cardiovasc Imaging. 2015;8:1444–60.
29. Roy C, Slimani A, de Meester C, Amzulescu M, Pasquet A, Vancraeynest D,
et al. Associations and prognostic significance of diffuse myocardial fibrosis
by cardiovascular magnetic resonance in heart failure with preserved
ejection fraction. J Cardiovasc Magn Reson. 2018;20:55.
30. Mordi IR, Singh S, Rudd A, Srinivasan J, Frenneaux M, Tzemos N, et al.
Comprehensive echocardiographic and cardiac magnetic resonance
evaluation differentiates among heart failure with preserved ejection
fraction patients, hypertensive patients, and healthy control subjects. JACC
Cardiovasc Imaging. 2018;11:577–85.
31. Rosca M, Lancellotti P, Popescu BA, Piérard LA. Left atrial function:
pathophysiology, echocardiographic assessment, and clinical applications.
Heart. 2011;97:1982–9.
32. Santos AB, Roca GQ, Claggett B, Sweitzer NK, Shah SJ, Anand IS, et al.
Prognostic relevance of left atrial dysfunction in heart failure with preserved
ejection fraction. Circ Heart Fail. 2016;9:e002763.
33. Schuster A, Backhaus SJ, Stiermaier T, Navarra JL, Uhlig J, Rommel KP, et al.
Left atrial function with MRI enables prediction of cardiovascular events
after myocardial infarction: insights from the AIDA STEMI and TATORT
NSTEMI trials. Radiology. 2019;293:292–302.
34. Hoit BD. Left atrial size and function: role in prognosis. J Am Coll Cardiol.
2014;63:493–505.
35. Kowallick JT, Kutty S, Edelmann F, Chiribiri A, Villa A, Steinmetz M, et al.
Quantification of left atrial strain and strain rate using cardiovascular
magnetic resonance myocardial feature tracking: a feasibility study. J
Cardiovasc Magn Reson. 2014;16:60.
36. von Roeder M, Kowallick JT, Rommel KP, Blazek S, Besler C, Fengler K, et al.
Right atrial-right ventricular coupling in heart failure with preserved ejection
fraction. Clin Res Cardiol. 2019;109:54-66.
37. Mirsky I. Assessment of diastolic function: suggested methods and future
considerations. Circulation. 1984;69:836–41.
38. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular
properties via pressure-volume analysis: a guide for clinical, translational,
and basic researchers. Am J Physiol Heart Circ Physiol. 2005;289:H501–12.
39. Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to
diagnose heart failure with preserved ejection fraction: the HFA-PEFF
diagnostic algorithm: a consensus recommendation from the heart failure
association (HFA) of the European Society of Cardiology (ESC). Eur Heart J.
2019;40:3297–317.
40. Kleijn SA, Brouwer WP, Aly MF, Rüssel IK, de Roest GJ, Beek AM, et al.
Comparison between three-dimensional speckle-tracking echocardiography
and cardiac magnetic resonance imaging for quantification of left
ventricular volumes and function. Eur Heart J Cardiovasc Imaging. 2012;13:
834–9.
41. Wu L, Germans T, Güçlü A, Heymans MW, Allaart CP, van Rossum AC.
Feature tracking compared with tissue tagging measurements of segmental
strain by cardiovascular magnetic resonance. J Cardiovasc Magn Reson.
2014;16:10.
42. Amzulescu MS, De Craene M, Langet H, Pasquet A, Vancraeynest D, Pouleur
AC, et al. Myocardial strain imaging: review of general principles, validation,
and sources of discrepancies. Eur Heart J Cardiovasc Imaging. 2019;20:605–19.
43. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen
T, et al. Recommendations for the evaluation of left ventricular diastolic
function by echocardiography: an update from the American Society of
Echocardiography and the European Association of Cardiovascular Imaging.
J Am Soc Echocardiogr. 2016;29:277–314.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
...
論文の公開元へ
